Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

Item
http://www.wikidata.org/entity/Q34041767
Adverse events in patients taking macrolide antibiotics versus placebo for any indicationAdvances in the prevention, management, and treatment of community-acquired pneumonia2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theAssociation between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement networkAntimycobacterial Activity of a New Peptide Polydim-I Isolated from Neotropical Social Wasp Polybia dimorpha.Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.Does macrolide use confer risk of out-of-hospital cardiac arrest compared with penicillin V? A Danish national case-crossover and case-time-control study.Non-invasive Assessment and Symptomatic Improvement of the Obstructed Nose (NASION): a physiology-based patient-centred approach to treatment selection and outcomes assessment in nasal obstruction.
P2860

Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

Item
http://www.wikidata.org/entity/Q34041767
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@ast
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@en
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@nl
type
label
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@ast
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@en
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@nl
prefLabel
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@ast
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@en
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932